STEPHANIE OTT: Open Payments
NPI 1730638651 · WESTFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 19 payments from 7 companies in 2025. Trend: 2023 $186 · 2024 $199 · 2025 $537
Food & beverage: $458Education: $79
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $226 |
| Sumitomo Pharma America, Inc. | 3 | $86 |
| Exact Sciences Corporation | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Exeltis, USA Inc. | 2 | $44 |
| Sage Therapeutics, LLC | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: Veozah, GEMTESA, Cologuard Collection Kit, SLYND, ZURZUVAE, ELIQUIS, The Cologuard Plus Collection Kit, CAMZYOS.
Industry payments across MA — which companies pay providers there.
